 |
7 Diseases |  |
124 Trials |
|
124 Trials |  |
723 News |  |
| «12...234567891011121314 |
- Opsiria (sirolimus) / Santen
Trial primary completion date: Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (clinicaltrials.gov) - Jun 26, 2014
P2, N=52, Terminated, Sponsor: National Eye Institute (NEI)
Trial primary completion date: Feb 2016 --> May 2016
- | Opsiria (sirolimus) / Santen
Trial termination, Trial primary completion date: Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (clinicaltrials.gov) - Jun 26, 2014
P2, N=52, Terminated, Sponsor: National Eye Institute (NEI)
Enrolling by invitation --> Terminated | Trial primary completion date: Feb 2016 --> May 2016; On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur.
- | lignocaine / Generic mfg.
Trial initiation date: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (clinicaltrials.gov) - Jun 2, 2014
P2/3, N=500, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
No further recruitment will occur. Initiation date: Oct 2013 --> May 2014
- | lignocaine / Generic mfg.
Enrollment open: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (clinicaltrials.gov) - Jun 2, 2014
P2/3, N=500, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Initiation date: Oct 2013 --> May 2014 Not yet recruiting --> Recruiting
- Chirocaine (levobupivacaine) / Purdue, AbbVie
New P4 trial: Quadratus Lumborum Block for Percutaneous Nephrostomy (clinicaltrials.gov) - Apr 22, 2014
P4, N=40, Not yet recruiting, Sponsor: National Cancer Institute, Egypt
- || lignocaine / Generic mfg.
New P2/3 trial: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (clinicaltrials.gov) - Oct 6, 2013
P2/3, N=500, Not yet recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- || lignocaine / Generic mfg.
New P3 trial, Surgery: Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer (clinicaltrials.gov) - Aug 1, 2013
P3, N=1600, Recruiting, Sponsor: Tata Memorial Hospital
- lignocaine / Generic mfg.
Clinical: Transcranial Direct Current Stimulation Combined Sensory Modulation Intervention in Chronic Stroke Patients (clinicaltrials.gov) - May 2, 2013
P=N/A, N=60, Recruiting, Sponsor: National Taiwan University Hospital
- lignocaine / Generic mfg.
New P4 trial: Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy (clinicaltrials.gov) - Oct 28, 2012
P4, N=50, Completed, Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research
- lignocaine / Generic mfg.
Trial completion: Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy (clinicaltrials.gov) - Oct 28, 2012
P4, N=50, Completed, Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- | lignocaine / Generic mfg.
New P4 trial, Surgery: A Study to Assess Analgesic Efficacy of Intravenous Lignocaine (clinicaltrials.gov) - Oct 2, 2012
P4, N=134, Completed, Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research
- Opsiria (sirolimus) / Santen
New P2 trial: Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (clinicaltrials.gov) - Aug 28, 2012
P2, N=50, Enrolling by invitation, Sponsor: National Eye Institute (NEI)
- lignocaine / Generic mfg.
Trial initiation date: Subcutaneous Lidocaine For Cancer-Related Pain (clinicaltrials.gov) - Mar 25, 2012
P2/3, N=50, Recruiting, Sponsor: British Columbia Cancer Agency
Not yet recruiting --> Completed Initiation date: Aug 2011 --> Dec 2011
- lignocaine / Generic mfg.
Enrollment open: Subcutaneous Lidocaine For Cancer-Related Pain (clinicaltrials.gov) - Mar 25, 2012
P2/3, N=50, Recruiting, Sponsor: British Columbia Cancer Agency
Initiation date: Aug 2011 --> Dec 2011 Not yet recruiting --> Recruiting
- lignocaine / Generic mfg.
Trial completion, Biopsy: Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies (clinicaltrials.gov) - Nov 9, 2011
P=N/A, N=49, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- lignocaine / Generic mfg.
Trial completion: Lidocaine: Effect of Lidocaine in Chronic Cough (clinicaltrials.gov) - Sep 14, 2011
P4, N=30, Completed, Sponsor: University Hospital of South Manchester NHS Foundation Trust
No longer recruiting --> Completed Not yet recruiting --> Completed